US 6451309
Prophylactic and therapeutic monoclonal antibodies
expired A61KA61K2039/505A61P
Quick answer
US patent 6451309 (Prophylactic and therapeutic monoclonal antibodies) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/20